Albumin and multiple sclerosis: a prospective study from UK Biobank
Open Access
- 10 June 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1415160
Abstract
Background: Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system. While previous studies have indicated that albumin, the primary protein in human plasma, may exert influence on the inflammatory process and confer beneficial effects in neurodegenerative disorders, its role in the context of MS has been underexplored. Here, we aimed to explore the link between albumin and the risk of MS.Methods: Employing data from the UK Biobank, we investigated the association between baseline levels of serum and urine albumin and the risk of MS using Cox proportional hazards regression analysis.Results: A higher baseline level of serum albumin was associated with a lower risk of incident MS (HR=0.94, 95% CI: 0.91–0.98, P=7.66E-04). Subgroup analysis revealed a more pronounced effect in females, as well as participants with younger ages, less smoking and deficient levels of vitamin D. Conversely, no association was identified between baseline microalbuminuria level and risk of incident MS.Conclusion: Higher serum albumin level at baseline is linked to a reduced risk of MS. These results contribute to an enhanced understanding of albumin’s role in MS, propose the potential use of albumin as a biomarker for MS, and have implications for the design of therapeutic interventions targeting albumin in clinical trials.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFC2501200)
- Sichuan Provincial Science and Technology Support Program (2022ZDZX0023)
This publication has 26 references indexed in Scilit:
- Systemic inflammation and risk of Parkinson’s disease: A prospective cohort study and genetic analysisBrain, Behavior, and Immunity, 2024
- What Is Multiple Sclerosis?JAMA, 2022
- The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decadesMultiple Sclerosis and Related Disorders, 2022
- Availability of Fibrinogen/Albumin ratio in MS attackMultiple Sclerosis and Related Disorders, 2022
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosisNature Reviews Neurology, 2016
- Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1bJAMA Neurology, 2015
- Perivascular iron deposits are associated with protein nitration in cerebral experimental autoimmune encephalomyelitisNeuroscience Letters, 2014
- Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosisAnnals of Neurology, 2012
- Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)Journal of Neurology, 2010
- Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple SclerosisArchives of Neurology, 2005